We are live on ! Find out more
ADPT icon

Adaptive Biotechnologies
ADPT

187 hedge funds and large institutions have $732M invested in Adaptive Biotechnologies in 2024 Q3 according to their latest regulatory filings, with 32 funds opening new positions, 66 increasing their positions, 44 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

60% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 20

56% more call options, than puts

Call options by funds: $403K | Put options by funds: $259K

50% more repeat investments, than reductions

Existing positions increased: 66 | Existing positions reduced: 44

36% more capital invested

Capital invested by funds: $538M → $732M (+$194M)

6% more funds holding

Funds holding: 176 → 187 (+11)

3.84% less ownership

Funds ownership: 100.88% → 97.04% (-3.8%)

Holders
187
Holders Change
+11
Holders Change %
+6.25%
% of All Funds
2.69%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.03%
New
32
Increased
66
Reduced
44
Closed
20
Calls
$403K
Puts
$259K
Net Calls
+$144K
Net Calls Change
+$379K

Top Buyers

1
BWLSA
Blue Water Life Science Advisors
California
+$9.35M
2
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group
Japan
+$3.63M
3
NAMA
Nikko Asset Management Americas
New York
+$3.55M
4
Goldman Sachs
Goldman Sachs
New York
+$3.05M
5
CC
Clearline Capital
New York
+$2.68M

Top Sellers

1
MCMC
Matrix Capital Management Company
New Hampshire
-$47.6M
2
Massachusetts Financial Services
Massachusetts Financial Services
Massachusetts
-$4.49M
3
TC
Tejara Capital
United Kingdom
-$3.29M
4
SCM
Soleus Capital Management
Connecticut
-$2.65M
5
Jane Street
Jane Street
New York
-$2.25M
Name Holding Trade Value Shares
Change 		Change in
Stake
EIM
26
Essex Investment Management
Massachusetts
$3.68M +$413K +94,831 +15%
Cerity Partners
27
Cerity Partners
New York
$3.56M +$1.12M +256,933 +59%
MCMC
28
Matrix Capital Management Company
New Hampshire
$3.33M -$47.6M -10,922,590 -94%
CC
29
Clearline Capital
New York
$3.15M +$2.68M +614,593 New
Tudor Investment Corp
30
Tudor Investment Corp
Connecticut
$2.64M +$1.69K +388 +0.1%
Jane Street
31
Jane Street
New York
$2.58M -$2.25M -517,256 -51%
Point72 Asset Management
32
Point72 Asset Management
Connecticut
$2.54M +$2.16M +495,492 New
DCM
33
Driehaus Capital Management
Illinois
$2.23M +$1.9M +435,294 New
Bank of New York Mellon
34
Bank of New York Mellon
New York
$1.89M -$394K -90,446 -20%
N
35
Nuveen
North Carolina
$1.82M – – –
CSS
36
Cubist Systematic Strategies
Connecticut
$1.53M +$1.3M +299,281 New
PP
37
PDT Partners
New York
$1.44M +$285K +65,378 +30%
MAG
38
Millrace Asset Group
Pennsylvania
$1.4M +$1.19M +272,681 New
AQR Capital Management
39
AQR Capital Management
Connecticut
$1.34M +$348K +79,888 +44%
LCM
40
Legato Capital Management
California
$1.24M +$138K +31,656 +15%
Fidelity Investments
41
Fidelity Investments
Massachusetts
$1.2M +$514K +117,965 +102%
Jennison Associates
42
Jennison Associates
New York
$1.19M +$235K +53,908 +30%
Barclays
43
Barclays
United Kingdom
$1.18M +$601K +137,936 +150%
Citadel Advisors
44
Citadel Advisors
Florida
$1.07M -$840K -192,696 -48%
RSWM
45
Robertson Stephens Wealth Management
California
$940K -$436 -100 -0.1%
Acadian Asset Management
46
Acadian Asset Management
Massachusetts
$908K +$774K +177,689 New
RhumbLine Advisers
47
RhumbLine Advisers
Massachusetts
$900K -$54.2K -12,444 -7%
Renaissance Technologies
48
Renaissance Technologies
New York
$867K +$76.7K +17,600 +12%
Invesco
49
Invesco
Georgia
$863K -$14.2K -3,254 -2%
UOC
50
UBS O'Connor
Illinois
$846K +$434K +99,529 +151%
1
2
3 4 5

ADPT Hedge Fund Activity: Q3 2024 in Review

187 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Adaptive Biotechnologies (ADPT) for Q3 2024, worth a combined $732M — up 36% from $538M a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new ADPT positions and 20 closed out — a net gain of 12 holders — while 66 added to existing stakes and 44 trimmed.

The largest buyer was Blue Water Life Science Advisors, opening a new position worth an estimated $9.35M. The largest seller was Matrix Capital Management Company, cutting an estimated $47.6M.

  • 187 institutional investors held Adaptive Biotechnologies (ADPT) as of Q3 2024, up from 176 in Q2 2024.
  • Funds reported $732M of Adaptive Biotechnologies stock for Q3 2024, up 36% quarter-over-quarter.
  • 32 funds opened new Adaptive Biotechnologies positions in Q3 2024 and 20 closed out, a net change of +12 holders.
  • The largest Adaptive Biotechnologies buyer in Q3 2024 was Blue Water Life Science Advisors, an estimated $9.35M added.
  • The largest Adaptive Biotechnologies seller in Q3 2024 was Matrix Capital Management Company, an estimated $47.6M sold.

Based on aggregated 13F filings for Q3 2024.